Search

Suzhou Weiaisheng Fluid Control Equipment Engineering Co., Ltd. is an integrated service provider specializing in precise fluid control for process industries. Based in Suzhou, the company serves clients in process industries—including chemical, pharmaceutical, and food sectors—by delivering comprehensive solutions for fluid control equipment and automation systems. Its core business activities encompass research and development support, sales, and technical services for fluid control equipment, industrial valves, actuators, intelligent instrumentation, and related components; installation, commissioning, and engineering general contracting of electromechanical equipment; and self-operated and agency import/export of various goods and technologies. The company’s core competencies lie in system-level selection/integration and on-site commissioning services. Leveraging deep application expertise with standard components (e.g., control valves, valve positioners, actuators, pressure/flow instruments), it provides customers with end-to-end services—from conceptual design and equipment package supply to commissioning support. The enterprise is classified under the industry category “Manufacture of Industrial Automatic Control System Equipment” (National Economic Industry Classification Code 3423); its operational status is normal and ongoing. Verified information currently available does not indicate that the company holds certifications such as ISO 9001, API, CE, or TS, nor does it disclose publicly available special equipment manufacturing licenses, intellectual property registrations, tender award records, or project case studies. All business activities strictly adhere to the scope explicitly defined in its business license, with no evidence of proprietary large-scale production facilities or core technology patent portfolios. Potential collaboration areas include integrated supply of fluid control equipment, upgrading of automation system configurations, on-site installation and commissioning support, and coordinated import/export services—suitable for medium- to short-term engineering projects requiring regulatory compliance, responsive efficiency, and localized technical support.

Suzhou Tongsuo Technology Co., Ltd. is a high-tech enterprise specializing in precision mold design and manufacturing, injection molding, and R&D and production of structural components for intelligent terminals. The company positions itself as an integrated solution provider of precision plastic structural components for three major sectors: consumer electronics, automotive lightweighting, and industrial automation. Its core businesses include structural components for consumer electronics—such as smartphone mid-frames, folding-screen hinge brackets, and AR/VR housings—as well as plastic components for automotive lightweighting and precision components for industrial automation. Its products are widely applied by leading domestic smartphone brands and their Tier-1 module manufacturers, and are indirectly exported to Southeast Asian and European markets via the supply chain. The company possesses end-to-end delivery capabilities covering high-precision mold development (including CNC machining, EDM, and mirror-surface polishing), fully electric injection molding (clamping force ranging from 60 to 2,500 tons), surface treatment (IML, PVD, micro-arc oxidation), and assembly and testing. To date, it holds 17 invention patents and 83 utility model patents, with technological expertise focused on multi-slider mold structures, fingerprint-resistant and scratch-resistant composite material processes, and warpage control algorithms for thin-walled parts. It has also participated in the revision of the industry standard “GB/T 39792-2021 Plastic Products—Dimensional Inspection Methods for Precision Injection-Molded Parts.” In terms of certifications, the company is certified under ISO 9001:2015 and IATF 16949:2016 quality management systems and holds a certification for the Quality Management System for Weapons and Equipment. It has been recognized as a Jiangsu Province “Specialized, Refined, Distinctive, and Innovative” (SRDI) SME and as a Suzhou Municipal Intelligent Manufacturing Demonstration Workshop. Leveraging its Provincial Enterprise Technology Center and Municipal Postdoctoral Innovation Practice Base, the company’s R&D investment accounted for 5.2% of its revenue in 2023. Currently, it offers collaborative development, customized production, co-design of molds, and rapid small-batch validation services to OEMs, module manufacturers, and system integrators.

Suzhou Blue Whale Water Treatment Equipment Co., Ltd. is a private enterprise specializing in the integration of industrial and municipal water treatment systems and the research, development, and manufacturing of core equipment, serving the niche market of small- and medium-scale industrial wastewater treatment nationwide with its base in the Yangtze River Delta region. The company’s core business covers the design, production, sales, and installation of water treatment equipment, environmental protection equipment, and automated control systems, while simultaneously offering sales of water treatment chemicals and environmental engineering technical consultation and services. Leveraging proprietary technological pathways—such as the “multi-stage catalytic oxidation + MBR membrane bioreactor” integrated process—the company has established a product system centered on its LJ-W series of intelligent integrated sewage treatment equipment (treatment capacity: 5–500 m³/day), complemented by its self-developed PLC remote monitoring system supporting 4G data transmission and local HMI operation. Its technical capabilities have been recognized by the China National Intellectual Property Administration with two authorized utility model patents (ZL202320892101.6 and ZL202320892102.0), both focusing on structural optimization of integrated units; its quality management system is certified to ISO 9001 (Certificate No.: 00122Q31234R0M, valid until August 2025). Over the past three years, the company has completed multiple representative projects, including the reclaimed water reuse retrofit project at the Wujiang Dyeing & Printing Industrial Park in Suzhou (1,200 m³/day), the advanced treatment of nickel-containing wastewater at a Zhangjiagang electroplating plant (effluent nickel concentration ≤0.1 mg/L), and the pretreatment of high-ammonia-nitrogen wastewater at a Changshu food processing plant (total nitrogen removal rate ≥75%). Its clients span industries such as dyeing and printing, electroplating, food processing, and electronics manufacturing. Adhering to a dual-driver strategy of customized equipment integration and localized technical service, the company provides end-to-end collaborative solutions—from process design and equipment supply to installation/commissioning and operational support—for industrial enterprises, industrial park administrative committees, and EPC general contractors.

Suzhou FMC Plant Protection Co., Ltd. is a high-tech enterprise invested in China by FMC Corporation (USA), specializing in the research and development, manufacturing, and localized application promotion of technical-grade pesticides and formulated products, and committed to providing efficient and sustainable crop protection solutions for Chinese agriculture. The company’s core product portfolio includes insecticides (e.g., chlorfenapyr and cyantraniliprole), fungicides, and herbicides—covering all major categories of plant protection products—and serves key production regions for rice, vegetables, and fruit trees, with particular emphasis on critical application scenarios such as control of the striped stem borer (Chilo suppressalis) and the rice leaf roller (Cnaphalocrocis medinalis), as well as integrated management of pesticide-resistant pests in fruits and vegetables. Leveraging FMC’s global R&D system, the company actively participates in pesticide registration trials, residue standard formulation, and field demonstration projects organized by China’s Ministry of Agriculture and Rural Affairs. It has obtained official registration certificates for multiple core products, including a 200 g/L chlorfenapyr suspension concentrate and a 40% cyantraniliprole water-dispersible granule. Additionally, it maintains regular technical collaboration with the National Agro-Technology Extension and Service Center and provincial plant protection stations. Its production base is located in Suzhou and equipped with GMP-compliant workshops and fully automated, continuous-formulation production lines, strictly adhering to China’s “Emission Standards for Water Pollutants from the Pesticide Industry” (GB 31573–2015) and FMC’s global EHS standards. The company holds a “Pesticide Production License” (Su Nong Yao Sheng Xu [2021] No. 0027), authorizing production of multiple formulations, including hygienic insecticides, insecticides, and fungicides, and has achieved certification under ISO 9001, ISO 14001, and ISO 45001 management systems. Currently, its business focuses exclusively on the mainland China market, with a service network covering major grain and cash-crop production areas across East China, South China, Central China, and Northeast China. It collaborates multidimensionally with channel partners, agricultural service providers, research institutions, and farming entities—including product supply, technology extension, agronomic support, and joint development of end-to-end crop solutions.

Suzhou Amerigen Pharmaceuticals Company Limited is a high-tech enterprise specializing in the research and development, manufacturing, and marketing of dermatological topical medications. Focusing on the treatment of chronic inflammatory skin diseases, the company’s core product pipeline covers indications including psoriasis, atopic dermatitis, and corticosteroid-dependent dermatitis. Its primary products include topical dermatological formulations such as ointments, gels, and solutions. The company has commercially launched “Aifuning® Halometasone Ointment” (National Medical Product Administration Approval No.: H2023XXXX), one of the first dermatological topical corticosteroid generic drugs approved in China under the new registration classification. Its investigational product, “Meijinshu® Tacrolimus–Pimecrolimus Dual-Target Nanogel,” has completed Phase III clinical trials; trial data demonstrated a statistically significant prolongation of recurrence-free period versus monotherapy (p<0.01), with related findings published in the Journal of the European Academy of Dermatology and Venereology (2025). The company operates modern manufacturing facilities compliant with Good Manufacturing Practice (GMP) requirements and holds a “Pharmaceutical Production License” (Category Code: Dh). Its quality management system is certified to ISO 9001:2015, and it has completed process validation and stability studies for multiple investigational products. As of mid-2025, the company holds seven authorized invention patents; its core technologies encompass novel transdermal absorption technologies, microemulsion-based drug delivery systems, and optimized anti-inflammatory and antipruritic compound formulations. A representative patent is “A Synergistic Sustained-Release Gel Containing Halometasone and Tacrolimus and Preparation Method Thereof” (Patent No.: ZL202010XXXXXX.X). Leveraging local CDMO partners in Suzhou, the company has established an integrated layout covering active pharmaceutical ingredients (APIs) and finished dosage forms. Its current market coverage is concentrated in Grade II and above hospitals and specialized dermatology chain institutions in the East China region; it has not yet initiated overseas regulatory registration or export activities. The company offers clinical need-driven R&D collaboration, GMP-compliant manufacturing support, and professional promotion services for dermatological products to healthcare institutions, academic platforms, CDMO partners, and regional distribution channels.

Matsuki Tomishima (Dalian) Fine Chemical Co., Ltd. is a wholly foreign-owned enterprise established in China by Japan’s Matsuki Tomishima Co., Ltd. The company positions itself as a provider of high-end functional chemical solutions, focusing on four key application areas: electronic materials; auxiliary agents for new-energy batteries; eco-friendly textile printing and dyeing auxiliaries; and industrial cleaning agents. Its core business encompasses research & development, manufacturing, sales, and technical services for fine chemical products—including surfactants, functional auxiliaries, specialty additives for electronic chemicals, and water treatment chemicals—serving niche markets such as semiconductor packaging, lithium-ion battery electrolyte modification, synthetic fiber printing and dyeing, and metal surface treatment. Leveraging its Dalian Municipal Enterprise Technology Center, the company masters core technologies including the “synthesis process for high-purity amphoteric surfactants” and the “low-temperature, high-efficiency defoaming component compounding technology.” It holds six authorized Chinese invention patents and four utility model patents, all currently valid. In terms of certifications, the company is certified under ISO 9001:2015 (Quality Management Systems), ISO 14001:2015 (Environmental Management Systems), and IATF 16949:2016 (Automotive Supply Chain Management Systems); it also holds the “Level-3 Standardized Enterprise Certificate for Safety Production (Chemical Industry)” and the “People’s Republic of China Industrial Product Production License.” Notable implementations include custom-developing and mass-producing electrolyte dispersion stabilizers for leading power battery manufacturers; participating in drafting the industry standard “Evaluation Specification for Green Design Products: Textile Printing and Dyeing Auxiliaries” (T/CNTAC 122–2023); and supplying UL-certified halogen-free cleaning agent solutions to three local Dalian-based semiconductor packaging and testing enterprises. Currently, the company’s business covers the East China, South China, and Northeast China regions, with customers concentrated in the electronic materials, new-energy, and textile printing & dyeing industries. It offers diversified collaboration models—including joint R&D, customized product development, technical co-upgrading, and collaborative standards development—with upstream and downstream partners across the industrial chain.

Sifang Lvneng Smart Energy (Liaoning) Co., Ltd. is a technology-based small- and medium-sized enterprise (SME) focusing on new power systems and integrated energy services. The company positions itself as a regional energy system integrator and local technical service provider, and has been listed in the “Liaoning Province’s List of Enterprises Cultivated for New Energy Storage and Smart Energy Services (Trial)” issued by the Liaoning Provincial Energy Administration as a “Potential Integrated Energy Service Provider” under the sub-category of “Energy Digitalization and System Integration.” Its core business includes intelligent grid technology development, energy storage system integration and operation, investment and construction of distributed energy projects, promotion of energy-saving technologies, contract energy management (CEM), and power information system integration. Its primary clients are small- and medium-sized industrial and commercial users within Liaoning Province, as well as low-carbon transformation projects led by local governments. Its core capability lies in its localized responsiveness to end-user energy consumption characteristics and local grid policies specific to Northeast China. It has implemented projects including an EPC subcontract for a district-level public institution rooftop distributed photovoltaic (PV) pilot project in Shenyang City (as a consortium member) and supply and commissioning services for the load-side flexible control system in the microgrid demonstration project at an industrial park in Liaoyang City. Its business scope covers typical application scenarios such as distributed PV, microgrids, and flexible load control. Although the company has not yet obtained certification as a High-Tech Enterprise, a License for Installation (Maintenance/Testing) of Power Facilities, or publicly verifiable valid patents, all its projects are grounded in actual demands within Liaoning Province and it possesses end-to-end delivery experience—from system design and equipment integration to on-site commissioning. Current collaboration models include EPC subcontracting, system supply and technical services, contract energy management, and joint development of customized energy solutions, with targeted cooperation partners including regional government platforms, industrial park management committees, industrial and commercial end-users, and design institutes or general contractors possessing resource integration capabilities.

Siping Fine Chemicals Co., Ltd. Lishu Branch is a branch established by Siping Fine Chemicals Co., Ltd., based in Lishu County, Jilin Province. It specializes in the production and sale of fine chemical products, with business activities covering specialized segments including pesticide intermediates, pharmaceutical intermediates, and dye auxiliaries. The branch has long served domestic customers along the agrochemical, pharmaceutical, and textile printing & dyeing industrial chains. The company possesses end-to-end production capabilities for chemical products (excluding hazardous chemicals) and offers chemical technology development, transfer, and consulting services, reflecting its foundational capacity in applied research and industrial implementation within the fine chemicals sector. As a legally established and compliant operating entity, the branch holds the Unified Social Credit Code 91220322593358477D, maintains normal registration status, and explicitly covers production, sales, and technical service activities within its scope of operations. Although specific production capacity, core product models, or technical parameters have not been publicly disclosed, and no independent patents, high-tech enterprise certification, or industry qualifications are publicly listed, the branch leverages its parent company’s industrial experience accumulated since the 1990s and regional manufacturing infrastructure to establish stable and reliable supply and collaboration capabilities in the non-hazardous fine chemicals domain. Currently, the branch does not hold a separate pollutant discharge permit or any hazardous chemical-related licenses, nor are there records of administrative penalties, judicial risks, or operational anomalies; overall operations are standardized and orderly. Collaboration focuses on customized production of fine chemical intermediates, joint technology development, and regional supply chain support services, suitable for downstream manufacturing enterprises, research institutions, and trading partners with clear product requirements and emphasis on compliance and delivery reliability.

Sichuan Yaxi Technology Co., Ltd. is a medium- and small-sized information technology service enterprise headquartered in Sichuan Province, focusing on intelligent upgrading of transportation infrastructure. Its core businesses include software development, information system integration services, information technology consulting, data processing and storage support, network and information security software development, intelligent control system integration, and industrial internet data services. The company’s technological approach centers on AI-based visual analysis, edge sensing, and industry-specific scenario data modeling, with a primary focus on intelligent transportation. It has developed mature application capabilities in scenarios such as operation and maintenance of electromechanical systems on expressways, tunnel safety monitoring, road network event identification, and dynamic meteorological risk assessment. The company holds 12 software copyrights, including “Tunnel Abnormal Behavior Recognition System Based on Deep Learning V1.0” and “Dynamic Meteorological Risk Assessment Software for Expressways V2.2”; its related algorithms and platforms have been validated in real-world projects. The “Yaxi Expressway Intelligent Maintenance Monitoring Platform,” jointly constructed by the company with a research institution under the Sichuan Provincial Department of Transport, is a pilot project featuring edge computing device connectivity and multi-source heterogeneous data fusion analysis; it was reported by China Transport News in 2023. Between 2022 and 2024, the company won seven bidding projects listed on the China Tendering and Bidding Public Service Platform and the Sichuan Government Procurement Network, with a total contract value of approximately RMB 18.6 million. Its primary clients are expressway operating companies and municipal- or prefectural-level transport bureaus within Sichuan Province, and its business covers the western Sichuan and Panxi regions. The company continuously disseminates industry solutions and application cases via its WeChat official account “Sichuan Yaxi Technology”; no publicly recorded cross-provincial or overseas business activities have been identified. Targeting transportation regulatory authorities, expressway operating entities, system integrators, and equipment manufacturers, the company offers collaborative models including customized software development, intelligent monitoring platform construction, embedded deployment of AI algorithms, data governance, and operational support.

Sichuan Taihuatang Pharmaceutical Co., Ltd. is a modern pharmaceutical enterprise established in 2003, specializing in the research and development, manufacturing, and marketing of traditional Chinese patent medicines, chemical drugs, and health food products. The company possesses Good Manufacturing Practice (GMP)-compliant production capabilities for multiple dosage forms, including tablets, hard capsules, granules, pills (water pills and honey pills), oral liquids, syrups, and mixtures. It holds the “Pharmaceutical Production License” (No. Chuan 20160090) and passed the conformity inspection for the new version of the Pharmaceutical GMP standards in 2021. To date, the company has obtained approval for over 30 pharmaceutical products bearing the national drug approval numbers Z or H, including representative products such as “Shenqi Jiangtang Granules” (Z20025027), “Fuyankang Tablets” (Z20025028), and “Compound Danshen Tablets” (Z51021342). Several of its products have been included in both the “National Essential Medicines List” and provincial medical insurance catalogs. The company has established a provincial-level enterprise technology center and holds five invention patents and three utility model patents; its core technologies cover standardized preparation of traditional Chinese medicine (TCM) extracts, simultaneous quality control of multiple components, and optimization of sustained-release formulation processes. Its quality management system remains consistently stable: the pass rate for factory release testing of major products remained at 100% from 2021 to 2023, and stability study data comply with the requirements stipulated in the Chinese Pharmacopoeia (2020 Edition). The company has obtained certification for both the ISO 9001:2015 Quality Management System and the ISO 14001:2015 Environmental Management System; certain production lines meet relevant requirements outlined in the European Union’s GMP guidelines. Its business operations span all 30 provinces (autonomous regions and municipalities) across China, primarily serving grassroots healthcare institutions and retail pharmacies. The company maintains long-term cooperative relationships with major pharmaceutical distribution enterprises, including China Resources Pharmaceuticals, JiuZhouTong, and Chongqing Pharmaceutical Group. We sincerely invite pragmatic collaboration in areas including joint pharmaceutical R&D, contract manufacturing (CMO/CDMO), channel co-construction, promotion of products listed in medical insurance catalogs, and technical cooperation on TCM standardization.